Zevra Therapeutics, Inc. (ZVRA) Operating margin 2019–2025
Zevra Therapeutics, Inc. (ZVRA) operating margin by fiscal year — reported operating income divided by reported revenue.
-59.1%FY2025 · since FY2019: -158.4% → -59.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -59.1% | +309.4 pp |
| FY2024 | -368.5% | -187.8 pp |
| FY2023 | -180.6% | +238.3 pp |
| FY2022 | -418.9% | -445.9 pp |
| FY2021 | 27.0% | +69.2 pp |
| FY2020 | -42.2% | +116.2 pp |
| FY2019 | -158.4% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More ZVRA financial trends
ZVRA RevenueZVRA Net incomeZVRA Net marginZVRA Gross profitZVRA Gross marginZVRA Operating incomeZVRA Operating cash flowZVRA Free cash flowZVRA Capital expendituresZVRA Return on equityZVRA Stock buybacksZVRA Dividends paidZVRA Total assetsZVRA Total liabilitiesZVRA Shareholders’ equityZVRA overview →